DE69728862D1 - Antivirale materialien - Google Patents

Antivirale materialien

Info

Publication number
DE69728862D1
DE69728862D1 DE69728862T DE69728862T DE69728862D1 DE 69728862 D1 DE69728862 D1 DE 69728862D1 DE 69728862 T DE69728862 T DE 69728862T DE 69728862 T DE69728862 T DE 69728862T DE 69728862 D1 DE69728862 D1 DE 69728862D1
Authority
DE
Germany
Prior art keywords
antiviral materials
antiviral
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728862T
Other languages
English (en)
Other versions
DE69728862T2 (de
Inventor
Mitsuru Akashi
Masanori Baba
Makoto Onishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69728862D1 publication Critical patent/DE69728862D1/de
Application granted granted Critical
Publication of DE69728862T2 publication Critical patent/DE69728862T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/20—Fabaceae or Leguminosae [Pea or Legume family], e.g. pea, lentil, soybean, clover, acacia, honey locust, derris or millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/963—Miscellaneous
DE69728862T 1996-08-08 1997-07-18 Antivirales ausgangsmaterial Expired - Fee Related DE69728862T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21032396 1996-08-08
JP8210323A JPH1045601A (ja) 1996-08-08 1996-08-08 抗ウイルス素材
PCT/JP1997/002501 WO1998006266A1 (fr) 1996-08-08 1997-07-18 Materiaux antiviraux

Publications (2)

Publication Number Publication Date
DE69728862D1 true DE69728862D1 (de) 2004-06-03
DE69728862T2 DE69728862T2 (de) 2004-11-04

Family

ID=16587530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728862T Expired - Fee Related DE69728862T2 (de) 1996-08-08 1997-07-18 Antivirales ausgangsmaterial

Country Status (5)

Country Link
US (1) US5945514A (de)
EP (1) EP0883993B1 (de)
JP (1) JPH1045601A (de)
DE (1) DE69728862T2 (de)
WO (1) WO1998006266A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1045601A (ja) * 1996-08-08 1998-02-17 Mitsuru Akashi 抗ウイルス素材
JP2001335510A (ja) * 2000-05-23 2001-12-04 Masanori Baba エイズワクチン
CN114875667A (zh) * 2022-04-14 2022-08-09 水木聚力接枝新技术(深圳)有限责任公司 一种基于双长链离子液体结构单体接枝共聚的广谱抗菌抗病毒纺织品及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
FR2586563B1 (fr) * 1985-09-03 1987-12-18 Pasteur Institut Lectines-facteurs d'attachement de neisseria gonorrhoeae, procede pour leur preparation et composition therapeutique contenant ces lectines ou les anticorps correspondants ou les recepteurs d'attachement correspondants
EP0628315A1 (de) * 1986-03-20 1994-12-14 Dana-Farber Cancer Institute, Inc. Lektinkomplexe und Sonden, sowie Verfahren zu ihrer Herstellung
US4882226A (en) * 1986-09-23 1989-11-21 Akzo N.V. Carrier material for use in chromatography or carrying out enzymatic reactions
CA1320718C (en) * 1987-06-08 1993-07-27 Richard Frederick Hammen Chromatographic material
JPH04503408A (ja) * 1989-02-21 1992-06-18 イーストマン コダック カンパニー 非多孔質単分散ポリマー充填物質を含む高速アフィニティクロマトグラフカラム
DD287950A5 (de) * 1989-09-15 1991-03-14 Adw Zi F. Molekularbiologie,De Verfahren zur kovalenten bindung von biologisch aktiven verbindungen an substituierte polyoxyalkylenglykole und ihre monoalkoxyderivate
CA2071546A1 (en) * 1989-10-25 1991-04-26 Derek Stewart Anti-viral material
US5284934A (en) * 1991-04-24 1994-02-08 Health Research Inc. Synthesis and utilization of carbohydrate-binding polymer-lectin conjugates
JP3139957B2 (ja) * 1995-03-17 2001-03-05 財団法人神奈川科学技術アカデミー レクチンの固定化法及びそれを用いた細胞用基材
JPH1045601A (ja) * 1996-08-08 1998-02-17 Mitsuru Akashi 抗ウイルス素材

Also Published As

Publication number Publication date
DE69728862T2 (de) 2004-11-04
US5945514A (en) 1999-08-31
EP0883993B1 (de) 2004-04-28
JPH1045601A (ja) 1998-02-17
EP0883993A4 (de) 2000-08-02
EP0883993A1 (de) 1998-12-16
WO1998006266A1 (fr) 1998-02-19

Similar Documents

Publication Publication Date Title
NO2003002I1 (no) Tadalafil
DE69717931D1 (de) Glasur-Auftragungsapparat
BR9709643A (pt) Compostos antivirais
IS4491A (is) Interferon tengd efni
ID18090A (id) Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
ID24176A (id) Bahan pembantu sementasi
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
NO984316D0 (no) Skjµreverkt°y
NO983462D0 (no) Isoleringsverkt°y
NO990552L (no) Innrettingsverkt°y
ID19490A (id) Kombinasi-kombinasi antiviral
ID20285A (id) Katrol tangan
BR9709432A (pt) Composto antivirais
DE69709597T2 (de) Opake Keramikbeschichtung
BR9709528A (pt) Compostos antivirais
FI972664A0 (fi) Foerseglad saeck med avluftning
DE69728862D1 (de) Antivirale materialien
ID18739A (id) Kombinasi-kombinasi antiviral
DE9402364U1 (de) Fliese
NO975818D0 (no) Sandblåsingsmaterialer
DE69829773D1 (de) Flammhemmende materialien
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
NO975819D0 (no) Sandblåsingsmaterialer
KR970007831U (ko) 김밥 말이용 김발
DE29512219U1 (de) Keramisches Übergangsteil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee